| Report ID | 193864 |
| Drug Identification Number | 00037915 |
| Brand name | DEXTROSE INJECTION USP |
| Common or Proper name | Dextrose Injection USP |
| Company Name | ICU MEDICAL CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500 mL |
| ATC code | B05BA |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-05-30 |
| Estimated end date | 2023-07-24 |
| Actual end date | 2023-07-25 |
| Shortage status | Resolved |
| Updated date | 2023-08-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 50 EAST BEAVER CREEK, UNIT #5 RICHMOND HILL, ONTARIO CANADA L4B 1G6 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-08-01 | French | Compare |
| v3 | 2023-08-01 | English | Compare |
| v2 | 2023-06-07 | French | Compare |
| v1 | 2023-06-07 | English | Compare |
Showing 1 to 4 of 4